Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-19-024971

Options or other derivatives

  • President & CEO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tesi Raymond Joseph · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-25 Grant or award : show line 1 in the form Option +300,000 700,000 D
Loading xslF345X03/ownership.xml…